Coherus Oncology, Inc. Share-based Payment Arrangement, Amount Capitalized
Coherus Oncology, Inc. (CHRS) reported Share-based Payment Arrangement, Amount Capitalized of $21.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-08-05
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $21.00K, a 51.16% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $33.00K, a 86.42% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $14.00K, a 95.33% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $19.00K, a 93.93% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for fiscal 2025 was $319.00K, a 77.33% decline from fiscal 2024.
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for fiscal 2024 was $1.41M.
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for fiscal 2022 was $1.19M, a 15.80% increase from fiscal 2021.
- Coherus Oncology, Inc. share-based payment arrangement, amount capitalized for fiscal 2021 was $1.02M, a 29.79% decline from fiscal 2020.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.00K 10-Q · filed 2026-08-05 | $54.00K 10-Q · filed 2026-08-05 | $68.00K derived: sum of 3 quarters · filed 2026-08-05 | $87.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $33.00K 10-Q · filed 2026-05-11 | $47.00K derived: sum of 2 quarters · filed 2026-05-11 | $66.00K derived: sum of 3 quarters · filed 2026-05-11 | $109.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $33.00K derived: sum of 2 quarters · filed 2026-03-09 | $76.00K derived: sum of 3 quarters · filed 2026-08-05 | $319.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $19.00K 10-Q · filed 2025-11-06 | $62.00K derived: sum of 2 quarters · filed 2026-08-05 | $305.00K 10-Q · filed 2025-11-06 | $605.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $43.00K 10-Q · filed 2026-08-05 | $286.00K 10-Q · filed 2026-08-05 | $586.00K derived: sum of 3 quarters · filed 2026-08-05 | $899.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $243.00K 10-Q · filed 2026-05-11 | $543.00K derived: sum of 2 quarters · filed 2026-05-11 | $856.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.26M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $613.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.01M derived: sum of 3 quarters · filed 2026-03-09 | $1.41M 10-K · filed 2026-03-09 |
| 2024-09-30 | $313.00K 10-Q · filed 2025-11-06 | $713.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.11M 10-Q · filed 2025-11-06 | $1.47M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-07 | $794.00K 10-Q · filed 2025-08-07 | $1.16M derived: sum of 3 quarters · filed 2025-11-13 | $1.53M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | $394.00K 10-Q · filed 2025-05-12 | $759.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.13M derived: sum of 3 quarters · filed 2025-11-13 | $1.32M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | $365.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-11-13 | $738.00K derived: sum of 2 quarters · filed 2025-11-13 | $931.00K derived: sum of 3 quarters · filed 2025-11-13 | $1.06M 8-K · filed 2025-11-13 |
| 2023-09-30 | $373.00K 10-Q · filed 2024-11-06 | $566.00K derived: sum of 2 quarters · filed 2024-11-06 | $697.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $193.00K 10-Q · filed 2024-08-08 | $324.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $131.00K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $1.19M 10-K · filed 2025-03-17 | |||
| 2021-12-31 | $1.02M 10-K · filed 2024-03-15 | |||
| 2020-12-31 | $1.46M 10-K · filed 2023-03-06 | |||
| 2019-12-31 | $1.74M 10-K · filed 2022-02-23 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |